Cite
HARVARD Citation
Jayoushe, M. et al. (n.d.). P040 Is Vedolizumab the Answer to Decreasing the Incidence of Immune-Mediated Colitis in Patients With Pre-Existing Inflammatory Bowel Disease?. American journal of gastroenterology. p. . [Online].